Paid

Study examines the effect of Mediterranean or low carb diet on weight, waist circumference and blood glucose in patients with obesity. 

Study identifies multiple risk factors for type 2 diabetes, including insomnia, that need to be incorporated into diabetes prevention strategies.

How important is GLP-1 RA effect on Hemoglobin A1c reduction in determining cardiovascular risk? 

The new approval of Wegovy™ is for a current medication, semaglutide, but more than doubling the standard dose for diabetes treatment. 

Pyroptosis causes cell death, leading to beta-cell dysfunction and diabetes mellitus.

Intensive insulin therapy may speed up the development of diabetic retinopathy, placing some patients at a higher risk for blindness. 

Central adiposity shows varying effects on blood pressure, LDL cholesterol, and glycemic profile. 

Study examines the complex relationship between type 2 diabetes, metformin use, and breast cancer subtype.

Lifestyle management and intervention alongside a once-weekly semaglutide dose of 2.4 mg. can lead to improved weight loss for patients with overweight or obesity.  

A combined pharmacological therapy showed efficacy in bodyweight reduction without lifestyle, diet, physical activity changes or surgery.